Within-animal variation as an indication of the minimal magnitude of the critical effect size for continuous toxicological parameters applicable in the benchmark dose approach

被引:18
作者
Dekkers, Susan
Telman, Jan
Rennen, Monique A. J.
Appel, Marco J.
Appel, Marco J.
de Heer, Cees
机构
[1] TNO Qual Life, NL-3700 AJ Zeist, Netherlands
[2] TNO Sci & Ind, NL-2600 AD Delft, Netherlands
关键词
adverse effect; benchmark approach; critical effect size; within-animal variation;
D O I
10.1111/j.1539-6924.2006.00784.x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
In this study, the within-animal variation in routinely studied continuous toxicological parameters was estimated from temporal fluctuations in individual healthy nonexposed animals. Assuming that these fluctuations are nonadverse, this within-animal variation may be indicative of the minimal magnitude of the critical effect size (CES). The CES is defined as the breaking point between adverse and nonadverse changes in a continuous toxicological parameter, at the level of the individual organism. The total variation in the data from individual nonexposed animals was divided in variation parts due to known factors (differences in sex, animal, and day) and a residual variation, by means of analysis of variance. Using the residual variation and the estimated analytical measurement error of a toxicological parameter, the within-animal variation can be estimated. The data showed within-animal variations ranging between 0.6% and 34% for different clinical chemistry and hematological parameters in 90-day rat studies. This indicates that different (minimal) CES values may be applicable for different parameters.
引用
收藏
页码:867 / 880
页数:14
相关论文
共 9 条
[1]   A NEW METHOD FOR DETERMINING ALLOWABLE DAILY INTAKES [J].
CRUMP, KS .
FUNDAMENTAL AND APPLIED TOXICOLOGY, 1984, 4 (05) :854-871
[2]   Critical effect sizes in toxicological risk assessment: a comprehensive and critical evaluation [J].
Dekkers, S ;
de Heer, C ;
Rennen, MAJ .
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2001, 10 (1-2) :33-52
[3]   Role of the standard deviation in the estimation of benchmark doses with continuous data [J].
Gaylor, DW ;
Slikker, W .
RISK ANALYSIS, 2004, 24 (06) :1683-1687
[4]  
*HLTH COUNC NETH, 2003, PUBL HLTH COUNC NETH
[5]  
Sebastian-Gambaro MA, 1997, EUR J CLIN CHEM CLIN, V35, P845
[6]   A probabilistic approach for deriving acceptable human intake limits and human health risks from toxicological studies: General framework [J].
Slob, W ;
Pieters, MN .
RISK ANALYSIS, 1998, 18 (06) :787-798
[7]   Dose-response modeling of continuous endpoints [J].
Slob, W .
TOXICOLOGICAL SCIENCES, 2002, 66 (02) :298-312
[8]  
*US EPA, 1995, EPA630R94007 US EPA
[9]   A probabilistic human health risk assessment for environmental exposure to dibutylphthalate [J].
Vermeire, T ;
Jager, T ;
Janssen, G ;
Bos, P ;
Pieters, M .
HUMAN AND ECOLOGICAL RISK ASSESSMENT, 2001, 7 (06) :1663-1679